Cargando…
Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy
Dystrophinopathic cardiomyopathy (DCM) is an almost constant manifestation in Becker muscular dystrophy (BMD) patients significantly contributing to morbidity and mortality. The nearly complete replacement of the myocardium by fibrous and fatty connective tissue results in an irreversible cardiac fai...
Autores principales: | Papa, Andrea Antonio, Gallinoro, Emanuele, Palladino, Alberto, Golino, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711328/ https://www.ncbi.nlm.nih.gov/pubmed/33305170 http://dx.doi.org/10.36185/2532-1900-018 |
Ejemplares similares
-
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results
por: PALLADINO, ALBERTO, et al.
Publicado: (2019) -
Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results
por: POLITANO, LUISA, et al.
Publicado: (2012) -
Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
por: Heyse, Alex, et al.
Publicado: (2019) -
Potential mechanisms of beneficial effect of sacubitril/valsartan on
glycemic control
por: Seferovic, Jelena P., et al.
Publicado: (2020) -
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020)